Skip to main content
. 2016 Nov 2;16:833. doi: 10.1186/s12885-016-2892-y

Fig. 1.

Fig. 1

Patients’ Disease free survival graphs according to HER2 status and their MBDs. Graphis depiciting DFS according to patients’ HER2 receptor status (p = 0.049) separately for patients in the (a) intermediate and (b) high risk NPI groups. Disease free survival graphs according to patients’ dichotomized mammographic density values. (p < 0.001) separately for patients in the (c) intermediate and (d) high risk NPI groups